Response to trametinib treatment in progressive pediatric low-grade glioma patients

INTRODUCTION: A hallmark of pediatric low-grade glioma (pLGG) is aberrant signaling of the mitogen activated protein kinase (MAPK) pathway. Hence, inhibition of MAPK signaling using small molecule inhibitors such as MEK inhibitors (MEKi) may be a promising strategy. METHODS: In this multi-center ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Selt, Florian, van Tilburg, Cornelis M., Bison, Brigitte, Sievers, Philipp, Harting, Inga, Ecker, Jonas, Pajtler, Kristian W., Sahm, Felix, Bahr, Annabelle, Simon, Michèle, Jones, David T. W., Well, Lennart, Mautner, Victor-Felix, Capper, David, Hernáiz Driever, Pablo, Gnekow, Astrid, Pfister, Stefan M., Witt, Olaf, Milde, Till
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609413/
https://www.ncbi.nlm.nih.gov/pubmed/33026636
http://dx.doi.org/10.1007/s11060-020-03640-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609413/
https://www.ncbi.nlm.nih.gov/pubmed/33026636
http://dx.doi.org/10.1007/s11060-020-03640-3

Ejemplares similares